Lydia Grmai was selected for the NIH MOSAIC program

The award, which aims to enhance diversity in the biomedical research workforce, will fund her career development and research for up to five years.

Inhaled Nanobodies Effective Against COVID-19 in Hamsters

Promising early data suggest that this approach can provide a convenient and cost-effective therapeutic option to control the coronavirus pandemic.

Why female brains are more resilient to aging

Pitt neuroscientists found that fruit flies, rodents and humans all have a protein called VGLUT that regulates sex differences in age-related neuron loss. It is not every day that scientists discover a phenomenon so fundamental across species.

Llama Nanobodies Could be a Powerful Weapon Against COVID-19

Research published today in Science describes a new method to extract tiny but extremely powerful antibody fragments from llamas, which could then be fashioned into inhalable therapeutics for COVID-19. Tune in today at 3 p.m. EST for a press conference on the findings.

Pitt Collaborates with Pharma Company on Eye Treatments

Debasish Sinha will work with Astellas Pharma Inc. in a new research collaboration to address dry age-related macular degeneration—a common cause of vision loss.

Alumna Sheds Light on Understudied Part of African American History

When Bridget Hunt-Tobey (MED ’19) took a course on human anatomy as part of Pitt’s Biomedical Master’s Program, she had no idea it would lead her to study bones of African American blast furnace workers in a first-ever internship program with the Smithsonian Institute.

Biologist who champions diversity in science wins recognition for career achievements

Professor Sandra Murray was recently named a lifetime fellow by the American Society for Cell Biology — the first African American woman to be honored with the recognition.